Results 121 to 130 of about 12,104 (196)

Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma. [PDF]

J Immunother Cancer
Tur-Planells V, Bykov Y, Dawodu G, García-Romero N, Izpura-Luis S, Pérez-Rodríguez L, Rius-Rocabert S, Palacín-Aliana I, Arranz-Herrero J, Márquez-Leiva I, Monago-Sanchez A, Del Rio ML, Rodriguez-Barbosa JI, Cano-Ochando J, García-Sastre A, Lozano-Ojalvo D, Nistal-Villan E, Ayuso-Sacido A, Cuadrado-Castano S.   +18 more
europepmc   +1 more source

Fusing Oncolytic Virotherapy With Cancer Immunotherapy to Treat Therapy-Resistant Melanoma. [PDF]

J Clin Oncol
Vile RG.
europepmc   +1 more source

Oncolytic Virotherapy for Glioma: A Bibliometric Roadmap for Multidisciplinary Clinical and Research Strategies. [PDF]

J Multidiscip Healthc
Liu S, Liang R.
europepmc   +1 more source

Multiparametric Detection of Effects of TILs and Oncolytic Virotherapy on Xenograft Mouse Model of Glioblastoma. [PDF]

Biomedicines
Yusubalieva GM, Chudakova DA, Shirokikh PG, Yuzhakova DV, Kiseleva EB, Sachkova DA, Dudenkova VV, Kirsova DP, Myzina MS, Yanysheva EP, Panov AV, Zakirova NF, Poteryakhina AV, Semikhin AS, Kalinkin AA, Baklaushev VP.   +15 more
europepmc   +1 more source

Resistance to oncolytic virotherapy: Multidimensional mechanisms and therapeutic breakthroughs (Review). [PDF]

Int J Mol Med
Xu J, Xia Z, Wang S, Xia Q.
europepmc   +1 more source

Durchbrechen von Therapieresistenzen [PDF]

, 2015

core   +1 more source

Oncolytic virotherapy -in vivo veritas

Oncotarget, 2018
Kemler, Iris, Neuhauser, Claudia, Dingli, David   +2 more
openaire   +2 more sources

Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment. [PDF]

Oncol Res
Feng Y, Yang H, Liang G, Chen J, Li T, Wang Y, Chang J, Li Y, Yang M, Zhou X, Wang Z, Ge C.   +11 more
europepmc   +1 more source

Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer. [PDF]

Front Immunol
Chen YC, Figueiredo ML.
europepmc   +1 more source

Experimental models for developing oncolytic virotherapy for metastatic prostate cancer. [PDF]

Front Immunol
Chen YC, Figueiredo ML.
europepmc   +1 more source